ISG15 and lung cancer: Subcutaneous xenografts derived from the two high ISG15 expressing lung cancer cell lines (H1975 and H358) showed higher sensitivity to inhaled and to a lesser extent IV topotecan compared to the moderate or no response seen in the low ISG15 expressing A549-derived tumors.